Case Study  ·  Technology Landscape

Getting therapies into the nucleus.

A global biopharmaceutical company wanted next-generation drug delivery vehicles. We landscaped four focus areas, from safety and immune response to nuclear targeting and endosomal escape, and tested hypotheses with experts.

The Client

The client is a global biopharmaceutical company. It wanted better delivery vehicles for its therapies.

The Challenge

Four hurdles.
Find vehicles that clear them.

Prescouter was asked to identify next-generation delivery vehicles for the client’s therapies across four areas: safety and immune response, nuclear localization and targeting, endosomal escape, and particle targeting.

  • Safety

    Immune response

    Lower immunogenicity and inflammation.

  • Nucleus

    Nuclear targeting

    Getting payloads to the nucleus.

  • Escape

    Endosomal escape

    Freeing payloads inside the cell.

Our Approach

Landscaping each area, then testing hypotheses.

Focus areas
4focus areas scoped

Scope each area

We set a defined scope for each area, starting with safety, immunogenicity and immune response.

Landscape scan
27technologies evaluated

Map the options

Our analysts searched the research for early-stage delivery technologies in each focus area.

Expert interviews
Expertinsight on key hypotheses

Test the hypotheses

Interviews with subject matter experts tested the most promising directions where needed.

The Outcome

A sharper view of drug delivery.

Prescouter evaluated 27 early-stage drug delivery technologies that advance nuclear localization and targeting or evade recognition and clearance by the innate immune system. The client gained clear insight into the delivery landscape and new approaches to strengthen its market reach.

  • Evaluated

    27 technologies

    Early-stage delivery vehicles.

  • Targeting

    Nuclear localization

    Approaches that reach the nucleus.

  • Stealth

    Immune evasion

    Avoiding innate immune clearance.

Delivery often decides whether a promising therapy reaches patients. Scanning early-stage science reveals options before they become crowded.

Let’s Talk

Which delivery vehicles could unlock your therapies?

Scope the problem, scan the science and test the most promising options. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address